Home›People›Richard Gaster
RG

Richard Gaster

Director at Entact Bio. Also a director at Aeovian Pharmaceuticals, Alumis and Attralus.

DirectorPublic companyRoles at 4 startups
Updated Nov 10, 2026·Latest SEC filing Jun 3, 2026·Suggest an edit

About Richard Gaster

Richard Gaster is a director at Entact Bio.

Form D filings also name Richard Gaster as a director at Aeovian Pharmaceuticals, Alumis and Attralus.

Richard Gaster reports to the SEC as a director of 2 public companies: Ventyx Biosciences (VTYX) and Elevation Oncology (ELEV).

Richard Gaster first appears on SEC filings in 2019.

Experience

This experience comes from Richard Gaster's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Gaster in the role, so the role may have started earlier or lasted longer.

Oak Hill Bio Current
Board Member
2026 – Present
Pediatric Brain Tumor Foundation Current
Board Member
2026 – Present
Myoventive Current
Board Member
2025 – Present
Entact Bio, Inc. Current
Director
2021 – Present · Watertown, MA
Develops medicines that enhance protein function for people with diseases.
Attralus, Inc. Current
Director
2020 – Present · Burlingame, CA
NorthSea Therapeutics B.V. Current
Board Member
2020 – Present
Aeovian Pharmaceuticals, Inc. Current
Director
2019 – Present · Berkeley, CA
Arrakis Therapeutics Current
Board Member
2019 – Present
venBio Partners Current
Managing Partner
2017 – Present
Yarrow Bioscience
Board Observer
2025 – 2026
35Pharma
Board Member
2022 – 2026
Alumis Inc.
Director
2024 · South San Francisco, CA
Ventyx Biosciences, Inc.
Director
2021 – 2023 · Public company (VTYX)
ACELYRIN, INC.
Board Member
2021 – 2023
Elevation Oncology, Inc.
Director
2021 · Public company (ELEV)
Pharvaris
Board Member
2019 – 2021
Harmony Biosciences
Board Observer
2017 – 2020
Akero Therapeutics
Board Observer
2018 – 2019
Pliant Therapeutics
Head of Translational Medicine
2016 – 2017
Third Rock Ventures
Senior Associate
2015 – 2016
wearBiō
Founder & Inventor
2013 – 2016

Key Colleagues at Startups

The people Richard Gaster works with at each company, as listed on that company's latest Form D.

Entact Bio, Inc. · Form D, Jun 3, 2026
AS
Anna French
Anna French
Director
Pini Orbach
Pini Orbach
Director
Victoria Richon
Victoria Richon
CEO, Board Member
OS
Owen Smith
Board Member
Aeovian Pharmaceuticals, Inc. · Form D, Dec 22, 2025
JK
John Kincaid
Executive officer
YB
TK
NR
Nils Regge
Director
DR
Davis Ryman
Executive officer
WG
MZ
Micah Zajic
Executive officer
LE
Lars Ekman
Director
JG
Justin Gover
Director
AH
Allison Hulme
Chief Executive Officer & Director
Alumis Inc. · Form D, Mar 11, 2024
ZY
Zhengbin Yao
Director
MB
Martin Babler
CEO and director
AC
JB
Julian Baker
Director
JT
Attralus, Inc. · Form D, Feb 9, 2024
MT
Mark Timney
Chief Executive Officer and Director
MK
Mehdi Khodadad
Executive officer
CG
GF
Glen Firestone
Executive officer
RK
Rahul Kakkar
Director
GB
Gregory Bell
Executive officer
SG
Spencer Guthrie
Executive officer
JT
James Testa
Executive officer
JB
Jake Bauer
Director
AD
Alex Denner
Director

Sources

  1. SECEntact Bio, Inc. Form D, filed Jun 3, 2026
  2. SECAeovian Pharmaceuticals, Inc. Form D, filed Dec 22, 2025
  3. SECAlumis Inc. Form D, filed Mar 11, 2024
  4. SECAttralus, Inc. Form D, filed Feb 9, 2024
  5. SECForms 3, 4 and 5 filed by Richard Gaster (SEC filer 1866026)